T1	Protein 897 908	VD receptor
T2	Protein 910 913	VDR
T23	Exp 324 337	a side effect
T24	Exp 724 732	ZK157202
T25	Exp 1602 1609	a model
R5	Coref Anaphora:T5 Antecedent:T23
R6	Coref Anaphora:T11 Antecedent:T24
R7	Coref Anaphora:T17 Antecedent:T16
R8	Coref Anaphora:T20 Antecedent:T25
T3	Exp 109 135	The biological active form
T4	Exp 243 254	the hormone
T5	Exp 339 344	which
T6	Exp 381 395	the regulation
T7	Exp 430 438	the need
T8	Exp 553 567	the importance
T9	Exp 571 593	the carbon-20 position
T10	Exp 605 620	the development
T11	Exp 734 739	which
T12	Exp 668 693	the biological properties
T13	Exp 697 719	the compounds ZK161422
T14	Exp 656 667	this report
T15	Exp 893 908	the VD receptor
T16	Exp 842 856	Both compounds
T17	Exp 949 979	their antiproliferative effect
T18	Exp 1123 1147	the hypercalcemic effect
T19	Exp 1201 1236	the same calcium-mobilizing potency
T20	Exp 1614 1619	which
T21	Exp 1650 1700	the selectively increased antiproliferative effect
T22	Exp 1576 1592	This observation
